Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Faucher

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantationRaynier Devillier, Samia Harbi, Sabine Fürst, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Experimental Hematology|September 21, 2010
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignanciesDidier Blaise, Laure Farnault, Catherine Faucher, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantationJean El-Cheikh, Raynier Devillier, Roberto Crocchiolo, et al.
European Journal of Haematology|March 6, 2012
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2015
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated DonorDidier Blaise, Sabine Fürst, Roberto Crocchiolo, et al.
Bulletin Du Cancer|May 9, 2026
[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)]Justine Nasone, Caroline Ballot, Ulrick Birba, et al.
Bulletin Du Cancer|April 23, 2019
[Related donors follow-up: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Alice Polomeni, Marjorie Culat-Farhat, Yohan Desbrosses, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignanciesEvgeny Klyuchnikov, Jean El-Cheikh, Andreas Sputtek, et al.
Bone Marrow Transplantation|December 23, 2017
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphomaJacopo Mariotti, Stefania Bramanti, Raynier Devillier, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 2014
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantationRaynier Devillier, Samia Harbi, Sabine Fürst, et al.
Cancer|February 5, 2015
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignanciesJean El-Cheikh, Roberto Crocchiolo, Sabine Furst, et al.
Experimental Hematology|September 21, 2010
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignanciesDidier Blaise, Laure Farnault, Catherine Faucher, et al.
Mediterranean Journal of Hematology and Infectious Diseases|May 14, 2013
Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantationJean El-Cheikh, Raynier Devillier, Roberto Crocchiolo, et al.
European Journal of Haematology|March 6, 2012
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myelomaJean El-Cheikh, Roberto Crocchiolo, Jean-Marie Boher, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 6, 2015
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated DonorDidier Blaise, Sabine Fürst, Roberto Crocchiolo, et al.
Bulletin Du Cancer|May 9, 2026
[Storage and disposal of cryopreserved cellular products and associated samples (SFGM-TC)]Justine Nasone, Caroline Ballot, Ulrick Birba, et al.
Bulletin Du Cancer|April 23, 2019
[Related donors follow-up: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Alice Polomeni, Marjorie Culat-Farhat, Yohan Desbrosses, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2013
CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignanciesEvgeny Klyuchnikov, Jean El-Cheikh, Andreas Sputtek, et al.
Bone Marrow Transplantation|December 23, 2017
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphomaJacopo Mariotti, Stefania Bramanti, Raynier Devillier, et al.
Pageof 8